The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.50
Bid: 85.00
Ask: 90.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.882%)
Open: 87.50
High: 87.50
Low: 87.50
Prev. Close: 87.50
TST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM & Trading Update

21 May 2008 08:07

RNS Number : 9407U
Belgravium Technologies PLC
21 May 2008
 



For Immediate Release

21 May 2008

Belgravium Technologies plc

(BVM:AIM)

AGM and Trading Update

At the Annual General Meeting of Belgravium Technologies plc ("Belgravium" or the "Company"), to be held at the offices of Buchanan Communications at 10.30 today, Chairman, John Kembery, will make the following statement:

"Belgravium delivered a solid set of results for 2007, showing an 11% increase in both profit before tax and earnings per share. Belgravium Ltd performed well and major benefits were derived from the successful integration of TouchStar and NovoIVC.

The company is not immune from wider global economic conditions and recent trading in 2008 has seen a slow down in the number of forward order contracts secured. The longer term pipeline of new projects remains very healthy although short-term visibility on when they might come to fruition, is poor. Although the company benefits from a good degree of repeat business, the lack of new contracts will produce a first half result substantially below expectations.

The Directors are committed to a growth strategy and are proposing no change in this policy. We continue to examine acquisition opportunities and have developed a new high specification product which will be launched shortly. Pre-production samples have received general acclaim and we have already gained agreement covering forward orders for 5000 units.

Customers have a real need for Belgravium systems and the efficiency savings they bring and cannot postpone purchases indefinitely. Almost no contracts have been lost to competitors but, as the purchasing decision is regarded as a capital project, it is subject to the severe financial constraints prevalent in the current market. Our analysis leads us to believe that this situation will be remedied later in the year and those sales and profits will be restored to the expected annual running rate by the final quarter.

Whilst Belgravium, like all Companies, is experiencing the effects of current markets, we are convinced and comforted that this is not driven by a permanent change in our specific industry and that the Company is positioned strongly to address demand once markets recover."

For further information please contact:

Buchanan Communications Ltd
Suzanne Brocks
020 7466 5000
 
 
Belgravium Technologies Plc
John Kembery
Mob: 07770 731021
 
 
WH Ireland
Gary Marshall
0113 394 6610
 
 
KPMG Corporate Finance
(Nominated Adviser)
Christian Mayo
0161 246 4000

 

 

 

 

 

KPMG Corporate Finance, a division of KPMG LLP which is authorized and regulated by the Financial Services Authority for investment business activities, is acting for the Company as nominated adviser in relation to the matters set out in this announcement and is not acting for any other person in relation to these matters. KPMG Corporate Finance will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQFLBLVEBEBBD
Date   Source Headline
30th Apr 202412:51 pmRNSAnnual Report & Notice of Annual General Meeting
17th Apr 20247:00 amRNSFinal Results
11th Mar 20247:00 amRNSTrading Update
16th Jan 20249:16 amRNSGrant of options
13th Dec 20237:00 amRNSDirector Appointment
9th Nov 202311:14 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20231:29 pmRNSInterim Results Correction
7th Sep 20237:00 amRNSInterim results
4th Aug 202311:25 amRNSHolding(s) in Company
4th Aug 20239:53 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSDirector Dealing
3rd Aug 20233:36 pmRNSTransaction in Own Shares & TVR
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSDividend Policy and Share Buy-Backs
22nd May 20232:54 pmRNSResult of AGM
26th Apr 20237:00 amRNSCapital Reduction
18th Apr 20237:00 amRNSFinal Results
23rd Jan 20237:00 amRNSTrading Update
8th Nov 20227:00 amRNSContract Award
3rd Oct 20229:28 amRNSGrant of options
15th Sep 20227:00 amRNSInterim Results
12th Aug 20229:12 amRNSHolding(s) in Company
26th Jul 20228:02 amRNSTrading Update
20th Jun 20223:00 pmRNSResult of AGM
26th Apr 20227:00 amRNSFinal Results
24th Jan 20227:00 amRNSFull Year Trading Update
20th Oct 202112:25 pmRNSHolding(s) in Company
13th Sep 20217:00 amRNSInterim Results
23rd Jun 20211:53 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
18th Jun 20211:00 pmRNSAGM Update
29th Apr 20214:42 pmRNSSecond Price Monitoring Extn
29th Apr 20214:39 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSPreliminary Results
13th Jan 20217:00 amRNSTrading Update
7th Sep 20207:00 amRNSInterim Results
30th Jun 202011:09 amRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
28th May 20207:00 amRNSFinal Results
1st Apr 20207:00 amRNSUpdate on trading and impact of Coronavirus
26th Feb 20203:07 pmRNSHolding(s) in Company
13th Feb 20208:25 amRNSHolding(s) in Company
5th Feb 20207:00 amRNSTrading Update
28th Jan 202010:57 amRNSHolding(s) in Company
23rd Jan 20201:45 pmRNSHolding(s) in Company
20th Dec 20199:12 amRNSDirector/PDMR Shareholding
18th Dec 20197:00 amRNSTrading Statement
10th Sep 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.